QNRX · Categories · Form 4

QNRX - SEC Form 4 insider transactions

Quoin Pharmaceuticals Ltd. (QNRX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for QNRX

• 71d
  SEC Form 4 filed by Stonepine Capital Management, Llc

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 124d
  SEC Form 4 filed by Chief Financial Officer Lawlor Sally Bridget

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 124d
  SEC Form 4 filed by Director Cooper Joseph Patrick

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 124d
  SEC Form 4 filed by Director Culverwell Anthony James

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 124d
  SEC Form 4 filed by Chief Executive Officer Myers Michael

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 124d
  SEC Form 4 filed by Chief Operating Officer Carter Denise P.

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 124d
  SEC Form 4 filed by Director Langer Dennis

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 124d
  SEC Form 4 filed by Director Sember Michael T

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 124d
  SEC Form 4 filed by Director Leong Natalie Ee Mun

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 189d
  SEC Form 4 filed by Chief Financial Officer Lawlor Sally Bridget

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 289d
  SEC Form 4 filed by Director Leong Natalie Ee Mun

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 289d
  SEC Form 4 filed by Director Culverwell Anthony James

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 289d
  SEC Form 4 filed by Director Langer Dennis

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 362d
  Amendment: SEC Form 4 filed by Chief Operating Officer Carter Denise P.

  4/A - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 362d
  Amendment: SEC Form 4 filed by Chief Executive Officer Myers Michael

  4/A - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 372d
  SEC Form 4 filed by Director Culverwell Anthony James

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 373d
  SEC Form 4 filed by Chief Executive Officer Myers Michael

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 373d
  SEC Form 4 filed by Chief Operating Officer Carter Denise P.

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 373d
  SEC Form 4 filed by Director Leong Natalie Ee Mun

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 373d
  SEC Form 4 filed by Director Langer Dennis

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 373d
  SEC Form 4 filed by Director Cooper Joseph Patrick

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 373d
  SEC Form 4 filed by Director Sember Michael T

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 547d
  SEC Form 4 filed by Director Cooper Joseph Patrick

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 547d
  SEC Form 4 filed by Chief Financial Officer Dunn Gordon

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 547d
  SEC Form 4 filed by Director Culverwell Anthony James

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 547d
  SEC Form 4 filed by Chief Operating Officer Carter Denise P.

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 547d
  SEC Form 4 filed by Director Sember Michael T

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 547d
  SEC Form 4 filed by Chief Executive Officer Myers Michael

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 547d
  SEC Form 4 filed by Director Leong Natalie Ee Mun

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 547d
  SEC Form 4 filed by Director Langer Dennis

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 730d
  Director Langer Dennis sold $217 worth of Ordinary Shares (297 units at $0.73), decreasing direct ownership by 85% to 53 units (SEC Form 4)

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 954d
  SEC Form 4 filed by Sember Michael T

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 954d
  SEC Form 4 filed by Dunn Gordon

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 954d
  SEC Form 4 filed by Myers Michael

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 954d
  SEC Form 4 filed by Culverwell Anthony James

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 954d
  SEC Form 4 filed by Cooper Joseph Patrick

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 954d
  SEC Form 4 filed by Leong Natalie Ee Mun

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 954d
  SEC Form 4 filed by Carter Denise P.

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)
• 954d
  SEC Form 4 filed by Langer Dennis

  4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)

Other QNRX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends